Although complement component 3 (C3), a prominent reactive astrocyte marker, has not been reported as a part of AD inflammatory progression and neurodegeneration, this marker is highly expressed in astrocytes of AD patients (Wu et al., 2019; Reichwald et al., 2009). Here, C3 is linked to Alzheimer disease.